Business

Prevention of epilepsy, based on the findings of Nencki Institute’s scientists is already in clinical trials

27.10.2023

This innovative therapy is designed to protect against the development of post-traumatic and post-stroke epilepsy. It is based on the research results on the role of MMP-9 enzyme in the process of epileptogenesis, by Prof. Leszek Kaczmarek and his team at the Laboratory of Neurobiology of the Nencki Institute. The laboratory operates within the Center of Excellence for Neural Plasticity and Brain Disorders BRAINCITY. Pikralida Sp. z o. o., the licensee of the rights to the invention of ...

Israeli Patent Granted for an invention from Nencki Institute and Case Western Reserve University

26.01.2023

We are pleased to inform that another patent has been granted for the invention "Prion protein-dendrimer conjugates for use in treatment of Alzheimer disease" by Krzysztof Nieznański, Hanna ...

Patent for a joint invention of the Nencki Institute and Warsaw University of Technology

24.01.2022

The subject of the invention is a flow microsystem of Lab-on-a-Chip type, which offers the possibility of imaging the dynamics of changes of insulin secreting pancreatic islet cells in a 3D ...

European Patent Granted for an invention from Nencki Institute and Case Western Reserve University

21.09.2021

The European Patent Office has issued a decision to grant a patent for an invention entitled "Prion protein-dendrimer conjugates for use in treatment of Alzheimer disease" (Patent No.: EP3468577; ...